Patent 9468550 was granted and assigned to Obalon Therapeutics on October, 2016 by the United States Patent and Trademark Office.
Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.